chapter 12
問題一覧
1
to administer a drug to an infected person that destroys the infective agent without harming the hosts cell
2
selectively toxic to the microbe but nontoxic to host cells, microbicidal rather than microbistatic, remains potent long enough to act and is not broken down or excreted prematurely, is not subject to the development of antimicrobial resistance, complements or assists the activities of the hosts defenses, remains active even when diluted in body fluids and tissues, readily delivered to the site of infection, reasonably priced, does not disrupt the hosts health by causing allergies or predisposing the host to other infections
3
any chemical used in treatment, relief, or prophylaxis of a disease
4
any antimicrobial drug, regardless of it’s origin
5
substances produced naturally by some microorganisms that inhibit or destroy other microorganisms
6
drugs that are chemically modified in the laboratory after being isolated from natural sources
7
antimicrobial compounds synthesized in the laboratory
8
antimicrobials effective against a limited number of bacteria; for example, a drug effective on gram positive bacteria only
9
effective against a large variety of microbial species; for example, a drug effective against both gram positive and gram negative bacteria. Can lead to a superinfection (examples: yeast infections caused by Candida albicans yeast or colitis caused by clostridium difficile)
10
use of a drug to prevent potential for infection in a person at risk
11
the use of chemotherapeutic drugs to control infection
12
produced by some bacteria and fungi
13
bacteria in genera streptomyces and bacillus, fungi in genera penicillium and cephalosporium, penicillin is the first antibiotic discovered
14
first to develop screening methods: tested wide variety of compounds to identify antimicrobials, found an arsenic compound that target syphilis
15
the first synthetic antimicrobial developed. it served as the starting point for development of a family of sulfa drugs. these types of drugs inhibit bacterial metabolic pathways
16
determined the structure of penicillin, which was fundamental to develop semi-synthetic penicillins
17
actinomyces, streptomyces, actinomycin, streptomycin, neomycin
18
slows the growth but does not kill the bacteria
19
kill the target bacteria
20
class of antibiotics that block the biosynthesis of peptidoglycan (bacteria more suspectible to osmotic lysis) Penicillin and it’s derivatives are all b-lactams
21
inhibition of cell wall synthesis (penicillins and cephalosporins), breakdown of the cell membrane structure or function (examples: polymyxins in bacteria affect mostly gram negative bacteria), interference with functions of DNA and RNA, inhibition of protein synthesis: ribosomes of bacteria are of different size (70s): (can target 30S or 50S subunits, inhibit peptide bond formation, or block attachment of tRNA, blocking essential metabolic pathways: (sulfa drugs)
22
drug competes with normal substrate for enzymes active site
23
it is toxic to fungal cells also capable of harming human cells
24
ergosterol because fungal sterol differs from animal cholesterol (example: imidazole drugs such as miconazole and ketoconazole), fungal membrane, fungal cell wall
25
block penetration into host cell, block replication, transcription, or translation of genetic material, prevent maturation of viral particles
26
drug inactivation, activation of drug pumps, change or mutation in drug binding site, use of alternate metabolic pathway
27
lowest concentration of antibiotic that inhibits growth (measured by turbidity)
lymphatic system part 2
lymphatic system part 2
ユーザ名非公開 · 29問 · 1年前lymphatic system part 2
lymphatic system part 2
29問 • 1年前respiratory system part 1
respiratory system part 1
ユーザ名非公開 · 28問 · 1年前respiratory system part 1
respiratory system part 1
28問 • 1年前respiratory part 2
respiratory part 2
ユーザ名非公開 · 32問 · 1年前respiratory part 2
respiratory part 2
32問 • 1年前respiratory part 3
respiratory part 3
ユーザ名非公開 · 12問 · 1年前respiratory part 3
respiratory part 3
12問 • 1年前urinary system part 1
urinary system part 1
ユーザ名非公開 · 23問 · 1年前urinary system part 1
urinary system part 1
23問 • 1年前urinary system part 2
urinary system part 2
ユーザ名非公開 · 18問 · 1年前urinary system part 2
urinary system part 2
18問 • 1年前urinary system part 3
urinary system part 3
ユーザ名非公開 · 28問 · 1年前urinary system part 3
urinary system part 3
28問 • 1年前artery and vein
artery and vein
ユーザ名非公開 · 8問 · 1年前artery and vein
artery and vein
8問 • 1年前trachea and esophagus
trachea and esophagus
ユーザ名非公開 · 8問 · 1年前trachea and esophagus
trachea and esophagus
8問 • 1年前tooth
tooth
ユーザ名非公開 · 7問 · 1年前tooth
tooth
7問 • 1年前stomach-pyloric
stomach-pyloric
ユーザ名非公開 · 8問 · 1年前stomach-pyloric
stomach-pyloric
8問 • 1年前ileum
ileum
ユーザ名非公開 · 6問 · 1年前ileum
ileum
6問 • 1年前chapter 27 fluid, electrolytes, and acid-base homeostasis
chapter 27 fluid, electrolytes, and acid-base homeostasis
ユーザ名非公開 · 27問 · 1年前chapter 27 fluid, electrolytes, and acid-base homeostasis
chapter 27 fluid, electrolytes, and acid-base homeostasis
27問 • 1年前chapter 28 reproductive system part 1
chapter 28 reproductive system part 1
ユーザ名非公開 · 32問 · 1年前chapter 28 reproductive system part 1
chapter 28 reproductive system part 1
32問 • 1年前chapter 28 reproductive system part 2
chapter 28 reproductive system part 2
ユーザ名非公開 · 24問 · 1年前chapter 28 reproductive system part 2
chapter 28 reproductive system part 2
24問 • 1年前chapter 29 development and inheritance
chapter 29 development and inheritance
ユーザ名非公開 · 31問 · 1年前chapter 29 development and inheritance
chapter 29 development and inheritance
31問 • 1年前chapter 29 development and inheritance part 2
chapter 29 development and inheritance part 2
ユーザ名非公開 · 20問 · 1年前chapter 29 development and inheritance part 2
chapter 29 development and inheritance part 2
20問 • 1年前lecture exam 2
lecture exam 2
ユーザ名非公開 · 25問 · 1年前lecture exam 2
lecture exam 2
25問 • 1年前chapter 13
chapter 13
ユーザ名非公開 · 45問 · 1年前chapter 13
chapter 13
45問 • 1年前chapter 14
chapter 14
ユーザ名非公開 · 19問 · 1年前chapter 14
chapter 14
19問 • 1年前lab exam 3 part 1
lab exam 3 part 1
ユーザ名非公開 · 15問 · 1年前lab exam 3 part 1
lab exam 3 part 1
15問 • 1年前chapter 15
chapter 15
ユーザ名非公開 · 21問 · 1年前chapter 15
chapter 15
21問 • 1年前chapter 16
chapter 16
ユーザ名非公開 · 17問 · 1年前chapter 16
chapter 16
17問 • 1年前chapter 18
chapter 18
ユーザ名非公開 · 20問 · 1年前chapter 18
chapter 18
20問 • 1年前chapter 19
chapter 19
ユーザ名非公開 · 14問 · 1年前chapter 19
chapter 19
14問 • 1年前lab exam part 2
lab exam part 2
ユーザ名非公開 · 19問 · 1年前lab exam part 2
lab exam part 2
19問 • 1年前chapter 20
chapter 20
ユーザ名非公開 · 10問 · 1年前chapter 20
chapter 20
10問 • 1年前chapter 22
chapter 22
ユーザ名非公開 · 9問 · 1年前chapter 22
chapter 22
9問 • 1年前chapter 23
chapter 23
ユーザ名非公開 · 7問 · 1年前chapter 23
chapter 23
7問 • 1年前chapter 24
chapter 24
ユーザ名非公開 · 7問 · 1年前chapter 24
chapter 24
7問 • 1年前chapter 25
chapter 25
ユーザ名非公開 · 8問 · 1年前chapter 25
chapter 25
8問 • 1年前問題一覧
1
to administer a drug to an infected person that destroys the infective agent without harming the hosts cell
2
selectively toxic to the microbe but nontoxic to host cells, microbicidal rather than microbistatic, remains potent long enough to act and is not broken down or excreted prematurely, is not subject to the development of antimicrobial resistance, complements or assists the activities of the hosts defenses, remains active even when diluted in body fluids and tissues, readily delivered to the site of infection, reasonably priced, does not disrupt the hosts health by causing allergies or predisposing the host to other infections
3
any chemical used in treatment, relief, or prophylaxis of a disease
4
any antimicrobial drug, regardless of it’s origin
5
substances produced naturally by some microorganisms that inhibit or destroy other microorganisms
6
drugs that are chemically modified in the laboratory after being isolated from natural sources
7
antimicrobial compounds synthesized in the laboratory
8
antimicrobials effective against a limited number of bacteria; for example, a drug effective on gram positive bacteria only
9
effective against a large variety of microbial species; for example, a drug effective against both gram positive and gram negative bacteria. Can lead to a superinfection (examples: yeast infections caused by Candida albicans yeast or colitis caused by clostridium difficile)
10
use of a drug to prevent potential for infection in a person at risk
11
the use of chemotherapeutic drugs to control infection
12
produced by some bacteria and fungi
13
bacteria in genera streptomyces and bacillus, fungi in genera penicillium and cephalosporium, penicillin is the first antibiotic discovered
14
first to develop screening methods: tested wide variety of compounds to identify antimicrobials, found an arsenic compound that target syphilis
15
the first synthetic antimicrobial developed. it served as the starting point for development of a family of sulfa drugs. these types of drugs inhibit bacterial metabolic pathways
16
determined the structure of penicillin, which was fundamental to develop semi-synthetic penicillins
17
actinomyces, streptomyces, actinomycin, streptomycin, neomycin
18
slows the growth but does not kill the bacteria
19
kill the target bacteria
20
class of antibiotics that block the biosynthesis of peptidoglycan (bacteria more suspectible to osmotic lysis) Penicillin and it’s derivatives are all b-lactams
21
inhibition of cell wall synthesis (penicillins and cephalosporins), breakdown of the cell membrane structure or function (examples: polymyxins in bacteria affect mostly gram negative bacteria), interference with functions of DNA and RNA, inhibition of protein synthesis: ribosomes of bacteria are of different size (70s): (can target 30S or 50S subunits, inhibit peptide bond formation, or block attachment of tRNA, blocking essential metabolic pathways: (sulfa drugs)
22
drug competes with normal substrate for enzymes active site
23
it is toxic to fungal cells also capable of harming human cells
24
ergosterol because fungal sterol differs from animal cholesterol (example: imidazole drugs such as miconazole and ketoconazole), fungal membrane, fungal cell wall
25
block penetration into host cell, block replication, transcription, or translation of genetic material, prevent maturation of viral particles
26
drug inactivation, activation of drug pumps, change or mutation in drug binding site, use of alternate metabolic pathway
27
lowest concentration of antibiotic that inhibits growth (measured by turbidity)